Four years later, Tsai et al. [23] concentrated on diabetes mellitus CKD patients and found that in this group of patients, Ang-2 was significantly associated with the risk of meeting not only hard renal endpoints, that is, dialysis commencement and rapid eGFR decline, but also MACEs and all-cause mortality. This evidence concerns the gene ANGPT2 and chronic kidney disease.